
2.39 Delayed Data As of Aug 12 | ![]() Today’s Change | 1.26 Today|||52-Week Range 6.86 | -36.27% Year-to-Date |
Previous close | 2.25 |
Today’s open | 2.35 |
Day’s range | 2.35 - 2.53 |
Volume | 40,381 |
Average volume (3 months) | 473,292 |
Market cap | $401.9M |
Earnings growth (last year) | -10.25% |
Earnings growth (this year) | -583.82% |
Earnings growth (next 5 years) | +5.60% |
Revenue growth (last year) | +54.14% |
P/E ratio | NM |
Price/Sales | 95.03 |
Price/Book | 1.87 |
Today’s change | Today’s % change | |
---|---|---|
XXII22nd Century Group I... | +0.01 | +0.83% |
---- | ||
SELBSelecta Biosciences ... | 0.00 | 0.00% |
TCRTAlaunos Therapeutics... | -0.13 | -7.02% |
Next reporting date | November 9, 2022 |
EPS forecast (this quarter) | -$0.29 |
Annual revenue (last year) | $6.1M |
Annual profit (last year) | -$158.1M |
Net profit margin | -2,570.99% |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Abingdon, Oxfordshire |